New Director to lead CTC

22/10/20

We are very pleased to officially welcome Professor Meg Jardine to the CTC to lead the centre into its next phase of growth and development.

The CTC and the University commenced an international search for a new CTC Director earlier in the year. Prof Jardine was previously Program Head of Innovation and Kidney Research at The George Institute and Head of Renal Trials at George Clinical. She is an accomplished clinical trialist and a practising nephrologist at Concord Repatriation General Hospital. For more, see her CTC profile.

CTC Founder and Director for the last 32 years Professor John Simes is stepping down from the Director role but will remain involved in CTC’s ongoing research program and other key initiatives.

Since establishing the CTC in 1988, Prof Simes has been instrumental in the development of clinical trials research with groups and experts across Australia and around the world. In addition to overseeing the expansion of the CTC to more than 230 staff working across multiple disciplines, Prof Simes has helped establish key industry organisations like Sydney Catalyst and the Australian Clinical Trials Alliance. For his life-long commitment, Prof Simes received the Cancer Achievement Award (MOGA), the Harvard Alum Award, was recently elected as a Fellow of the Australian Academy of Health and Medical Sciences, and was named on the Clarivate Analytics 2018 Highly Cited Researchers List. Thank you, John, for your tireless commitment to clinical trials research and improving the lives of patients.

Prof Jardine and Prof Simes will work together in the coming months to transition the CTC into its new era of leadership, consulting with senior CTC leaders and stakeholders, including the University’s Faculty of Medicine and Health (FMH).